November 20, 2014 Sanofi Rebuffs Renewed Lantus Cancer Worries A Swedish study has rekindled concerns about a possible link between Sanofi's top-selling insulin drug Lantus and cancer, but the French drugmaker said on Wednesday the observational research was seriously flawed
November 20, 2014 Oregon State Football Player Dies After Collapsing While Playing Basketball Oregon State announced that freshman defensive tackle Fred Thompson died Wednesday night after collapsing while playing basketball on campus
November 20, 2014 Sanofi Announces Positive Results for Diabetes Drug French drugmaker Sanofi said a late-stage study of its lixisenatide drug in combination with Lantus insulin showed a significant improvement in blood sugar levels and a beneficial effect on body weight in type 2 diabetes patients
November 20, 2014 GE, Microsoft in Healthcare Software Joint Venture General Electric Co and Microsoft Corp are forming a joint venture to develop and sell software systems to make it easier for healthcare providers to store, access and share patient information
November 20, 2014 Gene Therapy Used to Treat Blood Clotting Disorder Researchers made a major advance in the decades-old effort to use gene therapy to treat the bleeding disorder hemophilia B, reporting that six patients in a study started to make more of a crucial blood-clotting factor that prevents severe bleeding episodes
November 20, 2014 Some Depressed People Feel Worse on Medications, Study Says According to a new look at past antidepressant trials, up to a fifth of patients on Cymbalta and similar medications may actually do worse than those given drug-free placebo pills
November 20, 2014 Leukemia Drug Helps 47 Percent of Patients, Study Finds Early results from a pivotal trial of Ariad Pharmaceuticals Inc's experimental leukemia drug ponatinib show it is effective in nearly half of patients who had stopped responding to currently available drugs
November 20, 2014 Cancer Group Aims to Boost Trust in Guidelines In a field plagued by frequent controversy, the American Cancer Society has taken "a major step forward" with a new system for developing trustworthy screening recommendations
November 20, 2014 Medtronic Settles U.S. Probe Over Doctor Kickbacks Medtronic Inc has agreed to pay $23.5 million to settle allegations that it paid kickbacks to doctors to encourage them to use its pacemakers and defibrillators, the U.S. Justice Department said on Monday
November 20, 2014 Targeted Drug Side Effects Add to Cancer Costs Painful rashes and other skin-related side effects of newer targeted cancer drugs may jack up treatment costs, suggests a new study. The average cost of treating each cancer patient who came into a dermatology clinic with skin, hair and nail complaints was almost $2,000
